Article
SARS-CoV-2 uses major endothelial integrin αvβ3 to cause vascular dysregulation in-vitro during COVID-19.
PloS one - 1 Jan 2021
Nader Danielle, Fletcher Nicola, Curley Gerard F, Kerrigan Steven W
Abstract excerpt
The unprecedented global COVID-19 pandemic has prompted a desperate international effort to accelerate the development of anti-viral candidates. For unknown reasons, COVID-19 infections are associated with adverse cardiovascular complications, implicating that vascular endothelial cells are essential in viral propagation. The etiological pathogen, SARS-CoV-2, has a higher reproductive number and infection rate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
